| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/5/268:00 AM | -$0.35 | -$0.19GAAP | +45.7% | +85% | $50.5M | $68.3M | +35.3% | -3% | |
| Q2 '26 | 8/6/267:00 AM | -$0.37 | -$0.32GAAP | +13.5% | -152% | $51.7M | $56.7M | +9.8% | -76% | |
| Q1 '26 | 5/6/268:00 AM | -$0.23 | -$0.06GAAP | +73.9% | -102% | $76.9M | $139.5M | +81.5% | -79% | |
| Q4 '25 | 2/26/268:00 AM | -$0.56 | $0.11GAAP | +120% | +122% | $85.5M | $147.1M | +72.1% | +67% | |
| Q3 '25 | 11/6/257:48 AM | -$0.96 | -$0.48 | +50.0% | +37% | $42.8M | $70.4M | +64.7% | -17% | |
| Q2 '25 | 8/6/257:47 AM | -$0.12 | $0.62GAAP | +617% | -37% | $146.2M | $239.2M | +63.6% | -42% | |
| Q1 '25 | 5/8/258:00 AM | $0.19 | $2.93GAAP | ⚠ Check | +379% | $71.8M | $666.7M | ⚠ Check | +610% |
⚠ Potential error in calculation, check manually. The two EPS figures may be on different share counts (a stock split one source has not adjusted for). The two revenue figures may be in different units or currencies.
GAAP = diluted EPS as filed with the SEC. Other EPS figures are adjusted (non-GAAP), the basis analysts estimate.